Driehaus Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Driehaus Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-205,124	Closed	-$19.4M	–	546
2021 Q1	$19.4M	Sell	205,124 -77,525	-27%	-$9.22M	0.29%	106
2020 Q4	$34.4M	Sell	282,649 -4,268	-1%	-$468K	0.56%	48
2020 Q3	$25.1M	Buy	286,917 +40,648	+17%	+$2.83M	0.51%	52
2020 Q2	$15.9M	Sell	246,269 -34,970	-12%	-$2.02M	0.39%	76
2020 Q1	$12.6M	Buy	281,239 +13,741	+5%	+$730K	0.42%	67
2019 Q4	$16.7M	Buy	267,498 +66,268	+33%	+$3.15M	0.44%	61
2019 Q3	$7.57M	Sell	201,230 -6,054	-3%	-$264K	0.25%	111
2019 Q2	$8.44M	Buy	+207,284	New	+$7.39M	0.26%	103

Other funds holding TPTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Driehaus Capital Management's TPTX Position: Q2 2021 in Review

Driehaus Capital Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q2 2021, closing a stake of 205,124 shares — an estimated $19.4M sold.

Driehaus Capital Management first reported a position in TPTX in Q2 2019 and held it in 8 quarters. The position peaked at $34.4M in Q4 2020. 190 funds tracked by Wall St. Rank hold TPTX as of Q2 2021.

Driehaus Capital Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Driehaus Capital Management sold 205,124 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $19.4M.
Driehaus Capital Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
Driehaus Capital Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $34.4M in Q4 2020.
190 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Driehaus Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.